3Marin F, Roldan V, Climent VE, A Ibanez, et al. Plasma yon Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset nonrheumatic atrial fibrillation [ J ]. Heart,2004,90(10) :1162 - 1166.
4Benjamin EJ, Wolf PA, D' Agostino RB, et al. Impact of atrial fibrillation on the risk of death:the Framingham Heart Study[ J ]. Circulation, 1998,98 (10) :946 - 952.
6Parkash R,Green MS,Kerr CR,et al. The association of left atrial size and occurrence of atrial fibrillation: A prospective cohort study from the Canadian Registry of Atrial Fibrillation [ J ]. Am Heart J,2004,148(4) :649 - 654.
7Vaziri SM, Larson MG, Benjamin EJ, et al. Echocardiographic predictor of nonrheumatic atrial fibrillation : the Framingham Heart Study[ J]. Circulation, 1994,89 (2) :724 - 730.
8Sanfilippo ALl, Abaseal VM, Sheehan M, et al. Atrial enlargement a eonquence of atrial fibrillation : a prospective eehoeardiographic study [ J ]. Circulation, 1990,82 ( 3 ) : 792 -797.
9Caplan LR, D-Cruz I, Flier DB, et al. Atrial size, Atrial Fibrillation,and stroke [ J]. Ann Neurol, 1986,19 (2) : 158 - 161.
10Li-Saw-Hee FL, Blann AD, Lip GY. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation[ J]. J Am Coll Cardiol,2000,35 (7) :1926 - 1931.
7Romero J , Perez IE, Krumennan A, et al. Left atrial appendage closure devices. Clin Med Insights Cardiol , 2014, 8 :45-52.
8Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke, 1991, 22: 983 -988_.
9Blackahear JL, Odell JA_ Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation, Ann Thorac Surg, 1996, 61: 755-759.
10Thambidorai SK, MUITaY RD, Parakh K, et al. Utility of trans esophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol, 2005, 96: 935-941.
